Dr Boris Gorella appointed CEO of Master Builders Solutions under new ownership of Cinven
- Dr Boris Gorella appointed CEO
- Cinven assumes ownership
Master Builders Solutions welcomes Cinven as its new owner today, following the divestment as part of the remedial proceedings agreed by Sika to acquire MBCC Group.
At the same time, Dr Boris Gorella joins Master Builders Solutions with more than 20 years of experience in senior leadership roles, including significant experience in the chemical and basic materials industry and a proven track-record as CEO.
Boris Gorella, CEO of Master Builders Solutions, commented:
“I am very excited to join Master Builders Solutions, a company with world-class technologies, proven innovation capabilities, strong brands and very committed employees, at such a pivotal time for the business. As an independent company with construction chemicals at its core and under new ownership, I am looking forward to working with Master Builders Solutions' management and the Cinven team to help the business realise its full potential through new opportunities and a long-term growth strategy. Having previously worked for Master Builders Solutions, this feels somewhat like coming home."
Pontus Pettersson, Partner at Cinven, said:
“Cinven is delighted to commence this new chapter with Master Builders Solutions as an independent company. The business brings together a wealth of very attractive qualities including its global leadership in the sector, great potential for future growth and innovation, as well as a strong emphasis on sustainability. We are very much looking forward to supporting the business in the long-term and helping it realise its full potential through an organic and inorganic growth strategy, which is at the core of our DNA".
About Master Builders Solutions
Master Builders Solutions creates technologies for the construction industry inspiring people to build better. We are active in 36 countries and operate 35 production sites with over 1,600 employees. We develop, produce, and market high-quality chemical admixtures, cement additives, underground technologies, and construction systems to master the challenges of today and tomorrow.
Cinven is a leading international private equity firm focused on building world-class global and European companies. Its funds invest in six key sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials and Technology, Media and Telecommunications (TMT). Cinven has offices in London, New York, Frankfurt, Paris, Milan, Madrid, Guernsey and Luxembourg.
Cinven is familiar with the construction chemicals space as prior owner of Chryso and has extensive experience in industrial carve-outs, having executed more than 25 billion euros of such transactions since 2020, including the carve-outs of TK Elevator from thyssenkrupp AG (2020), Arxada (formerly Lonza Specialty Ingredients) from Lonza Group AG (2021) and Envu (formerly Bayer Environmental Science) from Bayer AG (2022). Cinven is one of the leading investors in the German-speaking region, with recent transactions including think-cell (2021) and dogado group (2023, combination with group.ONE), as well as Viridium Group (2019), STADA (2017) and Synlab (2015).
Cinven takes a responsible approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society.
Cinven Capital Management (V) General Partner Limited, Cinven Capital Management (VI) General Partner Limited, Cinven Capital Management (VII) General Partner Limited and Cinven Capital Management (SFF) General Partner Limited are each authorised and regulated by the Guernsey Financial Services Commission, and Cinven Limited, the advisor to the Cinven Funds, is authorised and regulated by the Financial Conduct Authority.
In this press release 'Cinven' means, depending on the context, any of or collectively, Cinven Holdings Guernsey Limited, Cinven Partnership LLP, and their respective Associates (as defined in the Companies Act 2006) and/or funds managed or advised by any of the foregoing.
For additional information on Cinven please visit